Anti-obesity compounds, Semaglutide and LiPR, do not change the proportion of human and mouse POMC+ neurons
Sara K. M. Jörgensen, May Surridge-Smith, Kimberley M. Jones, Lenka Maletı́nská, Nicholas D. Allen, David Petřík
The paper tests if anti-obesity drugs Semaglutide and LiPR affect POMC+ neuron proportions in human and mouse hypothalamic neurons, finding no significant changes.
bioRxiv · Dec 6, 2024 · PreprintNeuroscience